General Information of the Compound
| Compound ID |
CP0410987
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5-hydroxy-2,3,4,5-tetrahydro-1-benzazepin-1-yl)-[4-(3-methylpyrazol-1-yl)phenyl]methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H21N3O2
|
||||||||||||||||||
| Molecular Weight |
347.418
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccn(n1)-c1ccc(cc1)C(=O)N1CCCC(O)c2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H21N3O2/c1-15-12-14-24(22-15)17-10-8-16(9-11-17)21(26)23-13-4-7-20(25)18-5-2-3-6-19(18)23/h2-3,5-6,8-12,14,20,25H,4,7,13H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
QBJJGWYSANHTJY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01658, Oxytocin receptor
Protein ID: PT01839, Vasopressin V1a receptor
Protein ID: PT01648, Vasopressin V2 receptor